Skip to main content
logo
Poolbeg Pharma PLC (AIM:POLB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
6.20
-0.20 (-3.06%)
Oct 15, 2026, 2:11 PM GMT

Poolbeg Pharma Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-5.46-5.7-5.79-3.93-4.69-3.11
Depreciation & Amortization
0.070.060.110.030.030.02
Loss (Gain) From Sale of Assets
0.010.010.26---
Asset Writedown & Restructuring Costs
0.030.03-0.35--
Stock-Based Compensation
0.240.550.620.050.430.32
Other Operating Activities
-0.22-0.260.01-1.11-0.21-
Change in Accounts Receivable
0.10.190.150.21-0.46-0.67
Change in Accounts Payable
0.010.37-0.010.020.530.58
Operating Cash Flow
-5.23-4.76-4.65-4.38-4.37-2.86
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Sale (Purchase) of Intangibles
-0.13-0.08-0.13-0.18-0.6-0.11
Other Investing Activities
0.220.250.430.530.21-
Investing Cash Flow
0.090.170.30.36-0.39-0.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt Issued
-----0.3
Total Debt Repaid
------0.3
Issuance of Common Stock
-4.48---30.9
Financing Cash Flow
-0.014.48---30.9

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-5.14-0.11-4.35-4.02-4.7627.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-3.49-2.88-2.92-3.37-3.19-
Unlevered Free Cash Flow
-3.49-2.88-2.92-3.37-3.19-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.110.560.140.230.07-0.09